Diabetes Education News

Adults with type 1 diabetes who received tirzepatide in a real-world setting had reductions in HbA1c and body weight at 3 months that were sustained for up to 8 months, according to study data.

Adults with type 1 diabetes who have greater insulin sensitivity as measured by estimated glucose disposal rate are more likely to have better glycemic control, according to study data.

Rates of new-onset type 1 diabetes among children fell back to pre-pandemic levels in 2022 after sharply increasing in 2021, according to a population-wide analysis of data from Scotland published in Diabetes Care.

Maintaining high levels of physical activity and weight loss were associated with reduced risks for several cardiovascular events, a study published in JAMA Network Open showed.

The FDA is warning people with diabetes and the public that noninvasive smartwatches or smart rings that do not pierce the skin should not be used to measure blood glucose, according to a press release.

Adolescents who have an increase in fat mass are more likely to have worse insulin resistance as young adults, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.

In this video exclusive, Caroline T. Nguyen, MD, talks with Nicole Gomez, MD, about implications of prediabetes in pregnancy.

Hypercortisolism is prevalent among nearly one-quarter of people with difficult-to-control type 2 diabetes enrolled in a prospective phase 4 study, according to an industry press release.

The FDA granted fast track designation for an immunotherapy to treat type 1 diabetes among people with the human leukocyte antigen DR3-DQ2 genotype, according to a press release.

In 1999, the FDA approved the Medtronic MiniMed as the first continuous glucose monitor for people with diabetes. In the 25 years since that approval, use of diabetes technology has gradually increased.